Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Philip Low Insider Profile
11 Followers
Philip Low, Chief Science Officer, Director at Endocyte, holds 519.28K shares in Quince Therapeutics (Ticker: QNCX), holds 0.00 shares in Endocyte (Ticker: ECYT).
Philip Low Endocyte (ECYT)Chief Science Officer, Director
Endocyte (ECYT)
Chief Science Officer, Director
Ranked #7,851 out of 98,564 Corporate Insiders
Profitable Transactions
2 out of 7 Profitable Transactions
Average Return
+34.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Philip Low holds in companies
Most Profitable Insider Trade
Stock:
Endocyte
(ECYT)
(ECYT)
Rating:Informative Buy
Date:Nov 14, 2017 - Nov 14, 2018
Return:+395.30%
The most profitable trade made by Philip Low
Philip Low's Trading History
Endocyte
Dec 21, 2018
―
Uninformative Sell
11.58M
$0.00
Quince Therapeutics
May 23, 2022
Director
Uninformative Buy
―
$550.44K
List of latest transactions for each holding click on a transaction to see Philip Low's performance on stock
You May Also Like
Philip Low insider profile FAQ
What is the percentage of profitable transactions made by Philip Low?
The percentage of profitable transactions made by Philip Low is 29%.
What is the average return per transaction made by Philip Low?
The average return per transaction made by Philip Low is 34.30%.
What stocks does Philip Low hold?
Philip Low holds: ECYT, QNCX stocks.
What was Philip Low’s latest transaction?
Philip Low latest transaction was an Uninformative Buy of ―.
What was Philip Low's most profitable transaction?
Philip Low’s most profitable transaction was an Informative Buy of ECYT stock on November 14, 2017. The return on the trade was 395.30%.
What is Philip Low's role in Endocyte?
Philip Low's role in Endocyte is Chief Science Officer, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.